高级搜索

基于Web of Science数据库的肿瘤乏氧文献科学计量学分析

Global Status and Trends of Tumor Hypoxia: A Scientometric Analysis

  • 摘要:
    目的 利用科学计量学的分析方法探究肿瘤乏氧研究的发展现状、热点与前沿。
    方法 以Web of Science(WOS)数据库核心合集为数据源,系统检索与分析从建库至2018年12月31日收录的肿瘤乏氧文献,利用CiteSpace5.4.R1软件分别构建国家、机构、作者的合作网络及参考文献的共被引网络;利用VOSviewer1.6.10软件统计分析并构建关键词共现网络,并利用Excel2016统计分析肿瘤乏氧研究的年发表量、国家(包括H指数)、机构、期刊、作者及关键词的频次和引文情况。
    结果 共获得肿瘤乏氧文献4 933篇,1991年后发文量迅速增多。包含84个国家的3 604个研究机构的20 157位作者,其中发文量前3的作者分别是Vaupel P、Harris AL和Dewhirst MW,国家分别是美国、中国和英国,机构分别是多伦多大学、斯坦福大学和牛津大学。文献刊载于1 240种期刊上,刊文量前3的期刊分别是International Journal of Radiation Oncology Biology Physics(n=175, IF2017=5.554)、Cancer Research(n=144, IF2017=9.13)和Radiotherapy Oncology(n=114, IF2017=4.942)。共现100次以上的关键词聚为4类:肿瘤乏氧细胞与因子、肿瘤乏氧治疗、肿瘤乏氧诊断、肿瘤乏氧预后。关键词聚类结果结合引文分析结果提示,肿瘤乏氧的诊断与治疗是目前的研究热点。
    结论 欧美发达国家在肿瘤乏氧研究领域处于领先,肿瘤乏氧的诊断与治疗仍是难题,尤其是如何克服乏氧引起的耐药问题。

     

    Abstract:
    Objective This study aimed to explore the status quo, hot topics, and future prospects in the field of tumor hypoxia by scientometric analysis.
    Methods The literatures about tumor hypoxia were downloaded from the Web of Science Core Collection from inceptions to Dec.31st. 2018. We used CiteSpace 5.4.R1, VOSviewer 1.6.10 and Excel 2016 to analyze literature information, such as country, institution, author, keywords and references.
    Results A total of 4399 papers about tumor hypoxia were identified, involving 20157 authors from 3604 institutions in 84 countries. Vaupel P, Harris AL and Dewhirst MW published the most literatures. United States, China and United Kingdom contributed the most publications. The three most contributed institutions are the University of Toronto, Stanford University and Oxford University. International Journal of Radiation Oncology Biology Physics (n=175, IF2017=5.554), Cancer Research (n=144, IF2017=9.13) and Radiotherapy Oncology (n=114, IF2017=4.942) are the most productive journals. The main hot topics in tumor hypoxia field are tumor hypoxic cells and cytokines, tumor hypoxia therapy, tumor hypoxia diagnosis, tumor hypoxia prognosis.
    Conclusion Developed countries in Europe and America are dominant in the field of tumor hypoxia research. The diagnosis and treatment of tumor hypoxic is still a difficult problem, especially how to overcome the drug resistance caused by tumor hypoxic.

     

/

返回文章
返回